Tibet Rhodiola Pharmaceutical Holding Co Ltd (600211):企業の財務・戦略的SWOT分析

◆英語タイトル:Tibet Rhodiola Pharmaceutical Holding Co Ltd (600211) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82291FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tibet Rhodiola Pharmaceutical Holding Co Ltd (TRPHC) is a pharmaceutical company that manufactures and markets Chinese medicine. The company’s products include children shuangqing particles, little dragon capsule, nuodikang capsule, shuxioang capsules, snowy jin luohan analgesic balm, pu yu capsule and oral nuodikang. Its products are used for treating cough and asthama; headache, fever, throat infection, running nose, respiratory track infection, and urinary track infection. The company’s products are also used to treat rheumatoid arthritis, acute and chronic sprain, frozen shoulder, gout, limb and joint pain and soft tissue contusion. TRPHC is headquartered in Lhasa, Sichuan, China.

Tibet Rhodiola Pharmaceutical Holding Co Ltd Key Recent Developments

Mar 30,2021: Indicative announcement of Tibet Nuodikang Pharmaceutical Co., Ltd. on convening the 2020 Annual General Meeting of Shareholders
Feb 19,2021: Indicative announcement of Tibet Nuodikang Pharmaceutical Co., Ltd. on convening the first extraordinary general meeting of shareholders in 2021
Feb 10,2021: Announcement of Tibet Nuodikang Pharmaceutical Co., Ltd. on the resignation of independent directors
Feb 10,2021: Announcement on Resolutions of the Seventh Extraordinary Meeting of the Seventh Board of Directors of Tibet Nuodikang Pharmaceutical Co., Ltd.

This comprehensive SWOT profile of Tibet Rhodiola Pharmaceutical Holding Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Tibet Rhodiola Pharmaceutical Holding Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Tibet Rhodiola Pharmaceutical Holding Co Ltd – Key Information
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Overview
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Key Employees
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Key Employee Biographies
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Key Operational Heads
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Major Products and Services
Tibet Rhodiola Pharmaceutical Holding Co Ltd – History
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Company Statement
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Locations And Subsidiaries
Tibet Rhodiola Pharmaceutical Holding Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Tibet Rhodiola Pharmaceutical Holding Co Ltd – Business Description
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Corporate Strategy
Tibet Rhodiola Pharmaceutical Holding Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Strengths
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Weaknesses
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Opportunities
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Threats
Tibet Rhodiola Pharmaceutical Holding Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Tibet Rhodiola Pharmaceutical Holding Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Information
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Ratios
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Share Data
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Major Products and Services
Tibet Rhodiola Pharmaceutical Holding Co Ltd, History
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Employees
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Employee Biographies
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Operational Heads
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Other Locations
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Subsidiaries
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Key Competitors
Tibet Rhodiola Pharmaceutical Holding Co Ltd, SWOT Analysis
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Ratios based on current share price
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Annual Ratios
Tibet Rhodiola Pharmaceutical Holding Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Tibet Rhodiola Pharmaceutical Holding Co Ltd (600211):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Commercial International Bank (Egypt) S.A.E.:戦略・SWOT・企業財務分析
    Commercial International Bank (Egypt) S.A.E. - Strategy, SWOT and Corporate Finance Report Summary Commercial International Bank (Egypt) S.A.E. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Spectral Medical Inc (EDT):企業の財務・戦略的SWOT分析
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, whi …
  • Monsanto Co (MON):製薬・医療:M&Aディール及び事業提携情報
    Summary Monsanto Company (Monsanto) is an agricultural products manufacturing company. It develops and delivers agricultural products to support farmers all around the world. The company develops biotechnology traits that assist farmers in controlling insects and weeds. It also provides other seed c …
  • Concho Resources Inc.:企業の戦略・SWOT・財務分析
    Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Concho Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • GeneThera Inc (GTHR):企業の財務・戦略的SWOT分析
    Summary GeneThera Inc (GeneThera) is a biotechnology company that provides diagnostic services. The company develops molecular diagnostic tests, therapeutics, and vaccines to control emerging diseases in animals and in humans. Its products comprise Herd Guard, a Johne’s management solution; HerdChec …
  • MAB Discovery GmbH-製薬・医療分野:企業M&A・提携分析
    Summary MAB Discovery GmbH (MAB Discovery) is a drug discovery and development company that offers novel antibody therapeutics. The company produces monoclonal antibodies derived from rabbits and rats. It relies on natural immune response and state of the art B cell cloning techniques for the produc …
  • Pan Malaysia Holdings Berhad:企業の戦略・SWOT・財務分析
    Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Black River Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Black River Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Addnode Group AB (ANOD B):企業の財務・戦略的SWOT分析
    Summary Addnode Group AB (Addnode) is an information technology company that supplies software and services for construction, design, and product data information. The company's solutions include design management solutions, process management solutions, and product lifecycle management solutions, a …
  • Par Pacific Holdings, Inc. (PARR)-石油・ガス分野:企業M&A・提携分析
    Summary Par Pacific Holdings, Inc. (Par Pacific), formerly known as Par Petroleum Corporation, manages, owns and maintains interests in energy and infrastructure related businesses. It has operations across the value chain from natural gas production to distribution and transportation. The company c …
  • Amgen Inc (AMGN):企業の財務・戦略的SWOT分析
    Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Electricity Generating Authority of Thailand:企業の戦略・SWOT・財務分析
    Electricity Generating Authority of Thailand - Strategy, SWOT and Corporate Finance Report Summary Electricity Generating Authority of Thailand - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • American Express Company:企業の戦略・SWOT・財務情報
    American Express Company - Strategy, SWOT and Corporate Finance Report Summary American Express Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Eternygen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Eternygen GmbH (Eternygen) is a drug discovery company that offers research and development of innovative drugs for dietary-related metabolic diseases. The company’s product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transport …
  • Crew Energy Inc (CR):企業の財務・戦略的SWOT分析
    Summary Crew Energy Inc (Crew Energy) is an exploration and production company that offers our long-term production and development of crude oil and natural gas resources. The company offers exploration, development, strategic acquisitions, operations, management, and production programs. It operate …
  • Z Energy Ltd
    Z Energy Ltd - Strategy, SWOT and Corporate Finance Report Summary Z Energy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • JCB Co., Ltd.:企業の戦略・SWOT・財務情報
    JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • DexTech Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary DexTech Medical AB (DexTech) is a research company that conducts research in the areas of urological oncology, mainly within prostate cancer. The company develops product candidates based on a modified carbon hydrate molecule combined with active substances such as generics. Its technology p …
  • Integra LifeSciences Holdings Corporation:企業のM&A・事業提携・投資動向
    Integra LifeSciences Holdings Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Integra LifeSciences Holdings Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • The Quizno’s Master LLC:企業の戦略・SWOT・財務情報
    The Quizno’s Master LLC - Strategy, SWOT and Corporate Finance Report Summary The Quizno’s Master LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆